Altimmune, Inc. (ALT:NASDAQ) shot up at $3.7, a gain of 110.2%. On Thu 27 Feb 20, ALT:NASDAQ hit a New 2-Week Intraday High of $1.78. The stock got featured on our News Catalysts scanner on Fri 28 Feb 20 at 04:51 PM in the 'BIOTECH' category. From Thu 06 Feb 20, the stock recorded 42.86% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Altimmune, Inc. (ALT:NASDAQ)
Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 183.24%
- Biocept, Inc. (BIOC:NASDAQ), 168.87%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 143.21%
- Altimmune, Inc. (ALT:NASDAQ), 110.23%
- OpGen, Inc. (OPGN:NASDAQ), 66.18%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 62.9%
- Dynatronics Corporation (DYNT:NASDAQ), 59.34%
- Heat Biologics, Inc. (HTBX:NASDAQ), 54.93%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 54.64%
- Correvio Pharma Corp. (CORV:NASDAQ), 50.82%